Skip to main content

Publication, Part of

National Diabetes Inpatient Safety Audit 2022-23

Audit

Publication Date:
13 Jun 2024
Geographic Coverage:
England, Wales
Geographical Granularity:
Hospital Trusts
Date Range:
01 Nov 2018 to 31 Oct 2023

Current Chapter

National Diabetes Inpatient Safety Audit 2022-23

View all

Next Chapter

Data quality statement

Updates to column headings and 2023 data in Section 7: Inpatient harms rates

Please note that that figures 7c-7e in the detailed analysis file have been updated.

1) The headings in columns E and F of the table beneath Figure 7c have been updated to reflect the data: "Hospital bed days" (column E) and "DKA episodes" (column F).

2) Rows containing 2023 data in the tables beneath Figures 7c to 7e have been updated to include data for 1 January 2023 – 31 August 2023 (as stated in the text). Previously the included data only covered 1 January 2023 - 30 June 2023. Consequently the number of hospital bed days and episodes in 2023 have increased, although the corresponding rates per 100,000 hospital bed days have stayed the same to 1 decimal place.

26 June 2024 14:00 PM

Page contents

Summary

The National Diabetes Inpatient Safety Audit (NDISA) report covers: a) the provision of inpatient services in England and Wales on 1 October 2023; and b) diabetes-specific inpatient harms in England between November 2018 and October 2023.

Highlights

This is the second National Diabetes Inpatient Safety Audit (NDISA) report. NDISA has 2 core components:

A review of inpatient service provision in England and Wales, using the National Diabetes Audit (NDA) Integrated Specialist Services (ISS) Survey undertaken in October 2023. Service provision is assessed against recommendations in the 2020 Diabetes Getting It Right First Time (GIRFT) report.

A review of the rates and risk factors for serious diabetes-specific inpatient harms in England only, using the NDISA harms collection, a mandatory year-round collection of 4 harms that can occur to inpatients with diabetes in acute hospitals in England. The data collection started on 1 May 2018. The collection was previously known as National Diabetes Inpatient Audit (NaDIA) - Harms.

The NDISA 2022-23 release is a detailed analysis file with information on the inpatient questions from the October 2023 ISS survey and inpatient harms collected in NDISA between November 2018 and October 2023. Results are split into 7 sections:

  1. ISS 2023: Submitters
  2. ISS 2023: NDISA eligibility and coverage
  3. ISS 2023: NDISA results for England and Wales
  4. ISS 2023: NDISA results by nationality and region
  5. NDISA: Inpatient harms participation
  6. NDISA: Inpatient harms counts
  7. NDISA: Inpatient harms rates

Sections 1 to 4 use data from ISS 2023. Sections 5 to 7 use NDISA harms data linked to the core NDA and Hospital Episode Statistics (HES).

NDISA is part of the NDA portfolio within the National Clinical Audit and Patient Outcomes Programme (NCAPOP), commissioned by the Healthcare Quality Improvement Partnership (HQIP) and funded by NHS England and the Welsh Government.

Changes to NDA reporting

NHS England are currently reviewing the routine production of NDA State of the Nation reports. Please note that data will still be released via dashboards and standalone data files whilst this review is being conducted.

To help inform this review we would be grateful if users can provide feedback on their use of the State of the Nation reports using the feedback survey available in the ‘Related links' section of this page.

Last edited: 26 June 2024 12:19 pm

Pages in this publication